These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33600009)

  • 1. Anti-phosphatidylserine/prothrombin complex antibodies in patients with cutaneous vasculitis: Possible involvement in the pathogenesis.
    Kawakami T; Tamura Y; Dong Y; Yoshinari M; Nishibata Y; Masuda S; Tomaru U; Ishizu A
    J Dermatol; 2021 May; 48(5):703-706. PubMed ID: 33600009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in anti-phosphatidylserine-prothrombin complex antibodies and cutaneous vasculitis between regular livedo reticularis and livedo racemosa.
    Kawakami T; Yamazaki M; Mizoguchi M; Soma Y
    Rheumatology (Oxford); 2009 May; 48(5):508-12. PubMed ID: 19273539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa.
    Kawakami T; Yamazaki M; Mizoguchi M; Soma Y
    Arthritis Rheum; 2007 Dec; 57(8):1507-13. PubMed ID: 18050170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between lysosomal-associated membrane protein-2 and anti-phosphatidylserine/prothrombin complex antibody in the pathogenesis of cutaneous vasculitis.
    Kawakami T; Kikuchi A; Miyabe C; Ikeda T; Takeuchi S; Tamura Y; Nishibata Y; Masuda S; Nakazawa D; Tomaru U; Ishizu A
    Clin Exp Rheumatol; 2020; 38 Suppl 124(2):161-165. PubMed ID: 31994486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG phosphatidylserine/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers.
    Tonello M; Mattia E; Favaro M; Del Ross T; Calligaro A; Salvan E; Hoxha A; Fedrigo M; Ruffatti A
    Thromb Res; 2019 May; 177():157-160. PubMed ID: 30903876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of livedo racemosa, cutaneous inflammatory plaques, and antiphospholipid antibodies in patients with cutaneous polyarteritis nodosa.
    Kawakami T; Soma Y
    Medicine (Baltimore); 2011 Mar; 90(2):119-124. PubMed ID: 21358438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-phosphatidylserine/prothrombin antibodies in patients with polyarteritis nodosa.
    Sánchez-Cubías SM; Martín-Nares E; Hernández-Molina G; Nuñez-Alvarez CA; Sedano-Montoya MA; Vargas-Ruiz AG; Hinojosa-Azaola A
    Reumatol Clin (Engl Ed); 2021 Nov; 17(9):521-524. PubMed ID: 34756313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β
    Nakamura H; Oku K; Amengual O; Ohmura K; Fujieda Y; Kato M; Bohgaki T; Yasuda S; Atsumi T
    Arthritis Care Res (Hoboken); 2018 Apr; 70(4):627-634. PubMed ID: 28686816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Typical cutaneous small-vessel vasculitis induced by combined injection of antiphosphatidylserine/prothrombin complex antibody and anti-LAMP-2 antibody in normal rats.
    Kawakami T; Nakade I; Tamura Y; Ito F; Nishibata Y; Masuda S; Tomaru U; Ishizu A
    J Dermatol; 2022 Dec; 49(12):1233-1237. PubMed ID: 35876151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to phosphatidylserine/prothrombin (aPS/PT) enhanced the diagnostic performance in Chinese patients with antiphospholipid syndrome.
    Zhang S; Wu Z; Zhang W; Zhao J; Norman GL; Zeng X; Zhang F; Li Y
    Clin Chem Lab Med; 2018 May; 56(6):939-946. PubMed ID: 29561729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphosphatidylserine/prothrombin antibodies as biomarkers to identify severe primary antiphospholipid syndrome.
    Hoxha A; Mattia E; Tonello M; Grava C; Pengo V; Ruffatti A
    Clin Chem Lab Med; 2017 May; 55(6):890-898. PubMed ID: 27816952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.
    Hoxha A; Ruffatti A; Mattia E; Meneghel L; Tonello M; Salvan E; Pengo V; Punzi L
    Clin Chem Lab Med; 2015 Jul; 53(8):1265-70. PubMed ID: 25562605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome.
    Shi H; Zheng H; Yin YF; Hu QY; Teng JL; Sun Y; Liu HL; Cheng XB; Ye JN; Su YT; Wu XY; Zhou JF; Norman GL; Gong HY; Shi XM; Peng YB; Wang XF; Yang CD
    Clin Chem Lab Med; 2018 Mar; 56(4):614-624. PubMed ID: 29166262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a commercially available kit to detect anti-phosphatidylserine/prothrombin antibodies in a cohort of systemic lupus erythematosus patients.
    Sciascia S; Sanna G; Murru V; Khamashta MA; Bertolaccini ML
    Thromb Res; 2014 Mar; 133(3):451-4. PubMed ID: 24342537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of Anti-Phosphatidylserine/Prothrombin and Anti-Phosphatidylserine Antibodies with Pregnancy Outcomes.
    Xiang J; Pan Y; Bao R; Cai Z
    Am J Reprod Immunol; 2024 Jul; 92(1):e13890. PubMed ID: 38958240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a rat model of thrombosis induced by intravenous injection of anti-phosphatidylserine-prothrombin complex antibody.
    Yamada M; Kawakami T; Takashima K; Nishioka Y; Nishibata Y; Masuda S; Yoshida S; Tomaru U; Ishizu A
    Rheumatology (Oxford); 2017 Jun; 56(6):1013-1018. PubMed ID: 28073955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of antibodies to phosphatidylserine/prothrombin complex for antiphospholipid syndrome in Chinese patients.
    Zhu L; Li C; Liu N; Yang X; Jia RL; Mu R; Su Y; Li ZG
    Clin Rheumatol; 2017 Feb; 36(2):401-406. PubMed ID: 28050648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphosphatidylserine/prothrombin antibodies in primary antiphospholipid syndrome.
    Hoxha A; Ruffatti A; Tonello M; Bontadi A; Salvan E; Banzato A; Pengo V; Punzi L
    Lupus; 2012 Jun; 21(7):787-9. PubMed ID: 22635234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphosphatidylserine/prothrombin (aPS/PT) antibodies are associated with Raynaud phenomenon and migraine in primary thrombotic antiphospholipid syndrome.
    Kopytek M; Natorska J; Undas A
    Lupus; 2018 Apr; 27(5):812-819. PubMed ID: 29338587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort.
    Heikal NM; Jaskowski TD; Malmberg E; Lakos G; Branch DW; Tebo AE
    Clin Exp Immunol; 2015 May; 180(2):218-26. PubMed ID: 25522978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.